NSE
Mangalam Drugs And Organics LimitedMANGALAM
Mangalam Drugs And Organics Limited is an Indian pharmaceutical company focused on manufacturing and distribution of drugs and organic products.
| Key products | Pharmaceuticals, Organic Products |
|---|---|
| Geography | India |
| Competitors | Dr Reddy's Laboratories, Cadila Healthcare |
AI-generated overview — verify before relying on it.
Net institutional flow
−₹0 Cr
Institutional buyers
2 in / 3 out
High-impact filings
1 · tilt Neutral
Next corporate action
—
| # | Company | Inst. flow ₹Cr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | ATALREAL | +₹7.2 Cr | 157 | — | — | — | — |
| 2 | QUADFUTURE | +₹0.1 Cr | 148 | — | — | — | — |
| 3 | MOBIKWIK | +₹0.1 Cr | 83 | — | — | — | — |
| 4 | MTNL | +₹0 Cr | 2 | — | — | — | — |
| 5 | GATECH | +₹0 Cr | 8 | — | — | — | — |
| 6 | MANGALAMThis | −₹0 Cr | 19 | 1 | — | — | — |
| 7 | IRMENERGY | −₹2.2 Cr | 328 | — | — | — | — |
Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
- 2026-06-17FilingMangalam Drugs And Organics Limited has informed the Exchange about Fraud/Default/ArrestRisk
- 2026-06-17FilingMangalam Drugs And Organics Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) Shareholding Disclosure
- 2026-02-03BulkSELL · ₹1.3 CrNEO APEX VENTURE LLP
- 2026-02-03NetDay net −₹1.3 Cr
- 2026-02-02BulkBUY · ₹1.5 CrNEO APEX VENTURE LLP
- 2026-02-02NetDay net +₹1.5 Cr
- 2026-01-13BulkSELL · ₹0.6 CrJYOTIPRASAD TAPARIA
- 2026-01-13BulkSELL · ₹0.4 CrSANJAY KUMAR SAINI
- 2026-01-13NetDay net −₹1 Cr
- 2026-01-12BulkSELL · ₹0.8 CrASHUTOSH TAPARIA
- 2026-01-12BulkSELL · ₹0.3 CrSHIVKUMAR DAMANI
- 2026-01-12NetDay net −₹1.1 Cr
- 2026-01-08BulkBUY · ₹0.4 CrEPITOME TRADING AND INVESTMENTS
- 2026-01-08NetDay net +₹0.4 Cr
- 2026-01-07BulkSELL · ₹0.2 CrBONANZA PORTFOLIO LTD
- 2026-01-07BulkBUY · ₹0.3 CrBONANZA PORTFOLIO LTD
- 2026-01-07BulkSELL · ₹0.4 CrEPITOME TRADING AND INVESTMENTS
- 2026-01-07BulkSELL · ₹0.5 CrKEDIA SECURITIES PRIVATE LIMITED
- 2026-01-07BulkSELL · ₹0.4 CrMULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED
- 2026-01-07BulkSELL · ₹0.3 CrNEO APEX VENTURE LLP
- 2026-01-07BulkBUY · ₹0.2 CrSHARE INDIA SECURITIES LIMITED
- 2026-01-07BulkSELL · ₹0.3 CrSHARE INDIA SECURITIES LIMITED
- 2026-01-07NetDay net −₹1.7 Cr
- 2026-01-06BulkSELL · ₹0.6 CrAMBIKA FOOD INDUSTRIES PRIVATE LIMITED
- 2026-01-06BulkBUY · ₹0.4 CrEPITOME TRADING AND INVESTMENTS
- 2026-01-06BulkBUY · ₹0.3 CrNEO APEX VENTURE LLP
- 2026-01-06NetDay net +₹0.1 Cr
- 2025-12-29BulkBUY · ₹0.3 CrKEDIA SECURITIES PRIVATE LIMITED
- 2025-12-29NetDay net +₹0.3 Cr
Merged from deals, filings, corporate actions and news — newest first. Compact rolls each day up to net flow + counts. Scope with the range above.
Filings that matter
- 7
- 2Shareholding DisclosureNeutral
a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Source PDF →
19 deals · 2025-12-29 → 2026-02-03
| Date | Counterparty | Type | Side | Value |
|---|---|---|---|---|
| 2026-02-03 | NEO APEX VENTURE LLP | HNI / other | SELL | ₹1.3 Cr |
| 2026-02-02 | NEO APEX VENTURE LLP | HNI / other | BUY | ₹1.5 Cr |
| 2026-01-13 | JYOTIPRASAD TAPARIA | HNI / other | SELL | ₹0.6 Cr |
| 2026-01-13 | SANJAY KUMAR SAINI | HNI / other | SELL | ₹0.4 Cr |
| 2026-01-12 | ASHUTOSH TAPARIA | HNI / other | SELL | ₹0.8 Cr |
| 2026-01-12 | SHIVKUMAR DAMANI | HNI / other | SELL | ₹0.3 Cr |
| 2026-01-08 | EPITOME TRADING AND INVESTMENTS | Institution | BUY | ₹0.4 Cr |
| 2026-01-07 | BONANZA PORTFOLIO LTD | Institution | SELL | ₹0.2 Cr |
| 2026-01-07 | BONANZA PORTFOLIO LTD | Institution | BUY | ₹0.3 Cr |
| 2026-01-07 | EPITOME TRADING AND INVESTMENTS | Institution | SELL | ₹0.4 Cr |
19 deals in the selected window — corporate actions are scoped to the same period. ~2 years of history available.
News & chatter on MANGALAM
RSS News
0No recent news.
Google News RSS — links open the source.
Investdesk
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.